Tyrosine Kinase Inhibitors

Preferred Label : Tyrosine Kinase Inhibitors;

MeSH definition : Protein kinase inhibitors that inhibit TYROSINE PROTEIN KINASES.;

MeSH synonym : Inhibitors, Tyrosine Kinase; Kinase Inhibitors, Tyrosine; TKI Tyrosine Kinase Inhibitors; Tyrosine Kinase Inhibitor; Tyrosine Protein Kinase Inhibitors;

Détails

Origin ID

D000092004;

UMLS CUI

C4521478;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Record concept(s)
- Tyrosine Kinase Inhibitors [MeSH concept]
Semantic type(s)
- Qualitative Concept [UMLS semantic type]
Substance(s)
- (4-(4-(6-amino-5-(benzo(d)oxazol-2-yl)pyridin-3-yl)-1H-pyrazol-1-yl)piperidin-1-yl)ethanone [MeSH Supplementary Concept]
- (6,7-dimethoxy-2,4-dihydroindeno(1,2-c)pyrazol-3-yl)(3-fluorophenyl)amine [MeSH Supplementary Concept]
- 1-(3-(2H-1,2,3-triazol-2-yl)phenyl)-N-6-(2-aminocyclohexyl)-1H-pyrazolo(3,4-b)pyrazine-3,6-diamine [MeSH Supplementary Concept]
- 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine [MeSH Supplementary Concept]
- Afatinib [MeSH Descriptor]
- Crizotinib [MeSH Descriptor]
- Dasatinib [MeSH Descriptor]
- EGFR tyrosine kinase inhibitor 324674 [MeSH Supplementary Concept]
- Erlotinib Hydrochloride [MeSH Descriptor]
- G6 stilbenoid tyrosine kinase inhibitor [MeSH Supplementary Concept]
- Gefitinib [MeSH Descriptor]
- Imatinib Mesylate [MeSH Descriptor]
- Lapatinib [MeSH Descriptor]
- abivertinib [MeSH Supplementary Concept]
- acalabrutinib [MeSH Supplementary Concept]
- alectinib [MeSH Supplementary Concept]
- asciminib [MeSH Supplementary Concept]
- bosutinib [MeSH Supplementary Concept]
- ceritinib [MeSH Supplementary Concept]
- dacomitinib [MeSH Supplementary Concept]
- flumatinib [MeSH Supplementary Concept]
- gilteritinib [MeSH Supplementary Concept]
- ibrutinib [MeSH Supplementary Concept]
- mobocertinib [MeSH Supplementary Concept]
- neratinib [MeSH Supplementary Concept]
- nilotinib [MeSH Supplementary Concept]
- osimertinib [MeSH Supplementary Concept]
- pazopanib [MeSH Supplementary Concept]
- pirtobrutinib [MeSH Supplementary Concept]
- ponatinib [MeSH Supplementary Concept]
- quizartinib [MeSH Supplementary Concept]
- zanubrutinib [MeSH Supplementary Concept]
UMLS correspondences (same concept)
- Protein-tyrosine kinase inhibitor (disposition) [SNOMED CT concept]

Position du mot-clé dans l'(les) arborescence(s) :

Consulter ci-dessous une sélection des principales ressources :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients